New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

T he exact cause of Alzheimer’s disease has long evaded scientists, but experts typically suggest there are likely several ...

Becky and Benny were childhood sweethearts who went their separate ways in college. Now, she is his wife and caretaker as he ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Every couple of years it seems like another wave of stories emerge claiming picking your nose is a major causal factor in the ...

1️⃣ Drowning in debt: Americans are finding it harder to pay off their debt — specifically for auto loans and credit cards. In some cases, they haven’t been this overextended since the beginning of ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.

Experts in the fields of brain health, Alzheimer’s disease, caregiving and legal and long-term planning will speak to ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.